Anlon Healthcare Ltd.

₹25.56

1.2 (5%)

AHCL Share Price

Pharmaceuticals & Biotechnology

As on October 23, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,358.02 Cr

P/E Ratio47.64

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	25.87	Bearish
10-DMA	27.42	Bearish
20-DMA	29.43	Bearish
50-DMA	22.27	Bullish
100-DMA	18.72	Bullish
200-DMA	15.78	Bullish

Historical Performance

1 Year

104.1%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025
Net Sales	1,720	1,203
Total Expenditure	1,244	881
Other Income	3	2
Operating Profit	478	324
Interest	37	37
Depreciation	15	18
Profit Before Tax	425	269
Consolidated Net Profit	285	205
Adjusted EPS	1	1

Compounded Sales Growth

10 Years:7.4

5 Years:7.4

3 Years:7.4

TTM:7.4

Compounded Profit Growth

10 Years:6.8

5 Years:6.8

3 Years:6.8

TTM:6.8

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:105.4

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:N/A

last year:0.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025
Share Capital	532	399
Total Reserves	1,771	406
Long-Term Borrowings	---	---
Total Non-Current Liabilities	116	408
Other Current Liabilities	140	43
Short Term Borrowings	376	282
Total Liabilities	3,740	1,813
Capital Work in Progress	---	---
Long Term Loans & Advances	70	---
Currents Investments	---	9
Short Term Loans and Advances	856	298
Total Current Assets	3,083	1,585
Total Assets	3,740	1,813
Adjusted Book Value	4	2

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 47.64, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 178.6%, indicating sustained price appreciation.
The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹478 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1720 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2094052.1

No. of Shares: 81927 (Approx)

Performance:109.4%

1094052.1

NIFTY Performance: -12.4%

1 day Top Gainers